7:00 – 7:30 am
Breakfast Breakout Check-in & Networking Breakfast
Hosted by:
7:30 – 8:15 am
Breakout Sessions
MIGS
Moderator:
Steven Vold, MD
Participants:
John Berdahl, MD
Chris Calcaterra , Chief Commercial Officer – Glaukos
Richard Lewis, MD
Refractive Correction – Corneal & Intraocular
Moderator:
Vance Thompson, MD
Participants:
Eric Donnenfeld, MD
Rajesh K. Rajpal, MD , Chief Medical Officer – Avedro
John Vukich, MD
Breakfast with the FDA
Moderator:
Emmett T. Cunningham Jr., MD, PhD, MPH , Partner – Clarus Ventures
Participants:
Wiley Chambers , Deputy Director, Division of Transplant & Ophthalmology Products Center for Drug Evaluation & Research – FDA
Malvina B. Eydelman, MD , Director, Division of Ophthalmic & Ear, Nose & Throat Devices – FDA
Dry Eye
Moderator:
Edward Holland, MD
Participants:
Michael Ackermann, PhD , VP, Neurostimulation – Allergan
Kim Brazzell, PhD , Chief Medical Officer – Kala Pharmaceuticals
John Sheppard, MD
Innovative Alternatives to Drops
Moderator:
Richard Lindstrom, MD
Participants:
Mark Baum , CEO – Imprimis Pharmaceuticals
Adnan Butt , Biotechnology Analyst – RBC Capital Markets
Eugene de Juan, MD , Founder & Vice Chairman – ForSight Labs
Amar Sawhney, PhD , President, CEO & Chairman – Ocular Therapeutix
Hartaj Singh , Analyst – BTIG
8:00 – 8:45 am
General Attendance Check-in & Networking Breakfast
8:45 – 9:00 am
Summit Kick off with Ophthalmology Innovation Cycle & Financing Update
William J. Link, PhD , Managing Director – Versant Ventures
9:00 – 10:05 am
Ophthalmology Innovation Showcase
Moderators:
Susan Benton , Head, Ophthalmics Business Development – Shire
Jerry St. Peter , VP & Head, Ophthalmic Business – Sun Pharmaceutical Industries
Company Presentations
9:00 – 9:05 | PowerVision | Barry Cheskin , President, CEO & Co-Founder
9:05 – 9:10 | Refocus Group | Mike Judy , CEO
9:10 – 9:15 | ReVision Optics | John Kilcoyne , President & CEO
9:15 – 9:20 | Encore Vision | Bill Burns , President & CEO
9:20 – 9:25 | ClarVista Medical | Paul McLean , CEO
9:25 – 9:30 | Mynosys Cellular Devices | John Hendrick , President & CEO
9:30 – 9:35 | International Biomedical Devices | Mark Packer, MD , Chief Medical Officer
9:35 – 9:40 | Cassini | Mark Packer, MD , Chief Medical Officer
9:40 – 9:45 | TearScience | Joseph Boorady , President & CEO
9:45 – 9:50 | Aerie Pharmaceuticals | Tom Mitro , President & COO
9:50 – 9:55 | ForSight VISION5 | James Brandt, MD , Principal Investigator
9:55 – 10:00 | Ocular Therapeutix | Amar Sawhney, PhD , President, CEO & Chairman
10:00 – 10:05 | Avedro | Rajesh K. Rajpal, MD , Chief Medical Officer
10:05 – 10:30 am
Morning Networking & Refreshment Break
10:30 – 11:20 am
Diagnostics-Impact on the Premium Channel
Market Overview
Richard Lindstrom, MD
Company Presentations
Panel Discussion
Moderator:
Richard Lindstrom, MD
Participants:
Tom Frinzi , President – AMO, SVP – Abbott Laboratories
Dave Harmon , President – Market Scope
Warren Hill, MD
Ludwin Monz, PhD , President & CEO – Carl Zeiss Meditec AG
Jay Pepose, MD, PhD
Vance Thompson, MD
11:20 am – 12:00 pm
Spotlight on the Premium Channel
Market Overview
Elizabeth Yeu, MD
Company Presentations
Panel Discussion
Moderator:
Elizabeth Yeu, MD
Participants:
David Chang, MD
Eric Donnenfeld, MD
Sherman Reeves, MD, MPH
Denise Visco, MD
12:00 pm
Networking Lunch Commences
Hosted by:
12:50 – 1:15 pm
OIS LIFETIME INNOVATOR AWARD
Recipient:
Roger Steinert, MD
Interviewed By:
Stephen Lane, MD
1:15 pm
Lunch Concludes
1:15 – 1:55 pm
WTF@OIS: What’s the Future @OIS?
Unconventional innovations challenging conventional wisdom
Co-Moderators:
Gilbert H. Kliman, MD , Managing Director – InterWest Partners
Stephen Slade, MD
Company Presentations
1:55 – 2:25 pm
Afternoon Networking & Refreshment Break
2:25 – 3:05 pm
Spotlight on MIGS
MIGS is Growing Up: A Market Assessment
Ike Ahmed, MD
Company Presentations
Taking a MIGS company public: Glaukos | Chris Calcaterra , Chief Commercial Officer
Acquiring a MIGS company: Allergan | Dave LeCause , VP, US Eye Care
FDA and MIGS evolving guidance: Transcend | Sean Ianchulev, MD, MPH , Chief Medical Officer
Differentiating MIGS devices and the cataract surgeon: Ivantis | Dave Van Meter , President & CEO
Glaucoma device development beyond MIGS: InnFocus | Russ Trenary , President & CEO
Panel Discussion
Moderator:
Ike Ahmed, MD
Participants:
Robert Cionni, MD
Richard Lewis, MD
Jai G. Parekh, MD, MBA
3:05 – 3:55 pm
Masters of the Universe
Moderator:
Jim Mazzo , Executive Chairman & CEO – AcuFocus
Participants:
Mike Ball , CEO – Alcon
Tom Frinzi , President – AMO, SVP – Abbott Laboratories
William J. Link, PhD , Managing Director – Versant Ventures
Ashley McEvoy , Company Group Chairman – Johnson & Johnson Vision Care
William Meury , EVP, President Branded Pharma – Allergan
Ludwin Monz, PhD , President & CEO – Carl Zeiss Meditec AG
Calvin Roberts, MD , SVP & Chief Medical Officer – Bausch + Lomb
3:55 – 4:00 pm
Closing Remarks
Gilbert H. Kliman, MD , Managing Director – InterWest Partners
4:00 – 5:00 pm
Networking Reception
Hosted by: